TrueWealth LLC’s Amedisys AMED Stock Holding History

TrueWealth LLC’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$5K	Hold	23	–	–	﹤0.01%	555
2020 Q1	$4K	Hold	23	–	–	﹤0.01%	567
2019 Q4	$4K	Buy	+23	New	+$3.42K	﹤0.01%	585

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TrueWealth LLC's AMED Position: Q2 2020 in Review

TrueWealth LLC held its Amedisys (AMED) position steady in Q2 2020 at 23 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

TrueWealth LLC first reported a position in AMED in Q4 2019 and has held it in 3 quarters since. 355 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

TrueWealth LLC held 23 shares of Amedisys worth $5K as of Q2 2020.
TrueWealth LLC left its Amedisys share count unchanged in Q2 2020.
Amedisys made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #555 holding.
TrueWealth LLC first reported a position in Amedisys in Q4 2019 and has held it in 3 quarters since.
355 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.